145 related articles for article (PubMed ID: 34648610)
1. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma.
Zhu Q; Huang L; Yang Q; Ao Z; Yang R; Krzesniak J; Lou D; Hu L; Dai X; Guo F; Liu F
Nanoscale; 2021 Oct; 13(39):16457-16464. PubMed ID: 34648610
[TBL] [Abstract][Full Text] [Related]
2. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
[TBL] [Abstract][Full Text] [Related]
3. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
[TBL] [Abstract][Full Text] [Related]
4. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
[TBL] [Abstract][Full Text] [Related]
5. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
6. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
[TBL] [Abstract][Full Text] [Related]
7. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
[TBL] [Abstract][Full Text] [Related]
8. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
[TBL] [Abstract][Full Text] [Related]
9. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
[TBL] [Abstract][Full Text] [Related]
10. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
[TBL] [Abstract][Full Text] [Related]
11. New Metabolic Alterations and A Predictive Marker Pipecolic Acid in Sera for Esophageal Squamous Cell Carcinoma.
Liu L; Wu J; Shi M; Wang F; Lu H; Liu J; Chen W; Yu G; Liu D; Yang J; Luo Q; Ni Y; Jin X; Jin X; Chen WL
Genomics Proteomics Bioinformatics; 2022 Aug; 20(4):670-687. PubMed ID: 35351627
[TBL] [Abstract][Full Text] [Related]
12. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
Cheng J; Zheng G; Jin H; Gao X
Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
[TBL] [Abstract][Full Text] [Related]
13. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
[TBL] [Abstract][Full Text] [Related]
14. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
15. Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.
Matsumoto Y; Kano M; Akutsu Y; Hanari N; Hoshino I; Murakami K; Usui A; Suito H; Takahashi M; Otsuka R; Xin H; Komatsu A; Iida K; Matsubara H
Oncol Rep; 2016 Nov; 36(5):2535-2543. PubMed ID: 27599779
[TBL] [Abstract][Full Text] [Related]
16. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
[TBL] [Abstract][Full Text] [Related]
18. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
[TBL] [Abstract][Full Text] [Related]
19. Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma.
Wang PP; Song X; Zhao XK; Wei MX; Gao SG; Zhou FY; Han XN; Xu RH; Wang R; Fan ZM; Ren JL; Li XM; Wang XZ; Yang MM; Hu JF; Zhong K; Lei LL; Li LY; Chen Y; Chen YJ; Ji JJ; Yang YZ; Li J; Wang LD
Front Oncol; 2022; 12():790933. PubMed ID: 35155234
[TBL] [Abstract][Full Text] [Related]
20. Raman spectroscopy and machine learning for the classification of esophageal squamous carcinoma.
Huang W; Shang Q; Xiao X; Zhang H; Gu Y; Yang L; Shi G; Yang Y; Hu Y; Yuan Y; Ji A; Chen L
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121654. PubMed ID: 35878494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
